Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Center For Excellence In Molecular Cell Science Chinese Academy Of Scinces currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is being reviewed by 1 distinct examiner within 1 distinct art unit. This indicates a highly focused and singular point of prosecution for the company's current activities in this technical field.
The busiest examiner, MELCHIOR, JAMES RYLAND, is responsible for 1 pending office action. This individual is the sole examiner currently interacting with the company's pending portfolio. Because there is only 1 pending office action, the busiest examiner pending count is also 1. This concentration means that the company's immediate patent success in this area depends entirely on the review of this one examiner.
The presence of 1 distinct art unit confirms that the company's current work is being evaluated within a single specialized technical division. For practitioners, this means that the prosecution strategy can be very specific to the requirements of that one unit. The 1 pending office action represents the full extent of the company's current pending workload.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (25%) |
| Multi-statute (no §101) | 3 (75%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OTTON, ALICIA L | 1 | 64.9% | +9.4% |
| VALENROD, YEVGENY | 1 | 72.6% | +25.1% |
| STAVROU, CONSTANTINA E | 1 | 43.7% | +36.9% |
| ROGERS, ERIC JASON | 1 | 57.4% | +32.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18729910 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | OTTON, ALICIA L | — |
| 18728450 | CYCLOPIPERIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | VALENROD, YEVGENY | — |
| 18248443 | Method for Inducing Differentiated Cells Into Pluripotent Endoderm Stem Cells and Application Thereof | STAVROU, CONSTANTINA E | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17292296 | USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG | ROGERS, ERIC JASON | 8d |
| 18728450 | CYCLOPIPERIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | VALENROD, YEVGENY | — |
| 18248443 | Method for Inducing Differentiated Cells Into Pluripotent Endoderm Stem Cells and Application Thereof | STAVROU, CONSTANTINA E | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18729910 | TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | OTTON, ALICIA L | — | §102§112 | Non-Final OA | — | Pending | Jul 18, 2024 |
| 18728450 | CYCLOPIPERIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | VALENROD, YEVGENY | — | §102§103§112 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18248443 | Method for Inducing Differentiated Cells Into Pluripotent Endoderm Stem Cells and Application Thereof | STAVROU, CONSTANTINA E | 1632 | §102§103 | Final Rejection | — | Pending | Apr 10, 2023 |
| 17292296 | USE OF ECM1 GENE-KNOCKOUT MOUSE IN SCREENING OF ANTI-HEPATIC FIBROSIS DRUG | ROGERS, ERIC JASON | 1638 | §112 | Non-Final OA | 8d | Pending | Sep 15, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial